Here’s what you should know:
1. The scientists said defects in the fungus-fighting abilities of cells contribute to Crohn’s disease and other inflammatory bowel disease forms.
2. Iliyan Iliev, PhD, an assistant professor of microbiology and immunology at Weill Cornell, specializes in gut fungi research and is the senior author of the newly published study. Study researchers discovered a white blood cell, CX3CR1+, that acts as the immune system’s gut fungal regulator.
3. This white blood cell is responsible for the initiation of the gut’s immune response to fungus.
4. To test this, researchers created colitis in mice and added fungal cells to increase the severity of the illness. Mice that lacked CX3CR1+ were more susceptible to the disease than mice that had the aforementioned cell. Researchers then introduced an antifungal drug treatment which reversed the course of the disease in the mice without Cx3CR1+ indicating fungal overgrowth was the cause.
More articles on gastroenterology:
Takeda, Motus GI & more — 5 GI company key notes
Waterborne illness in the United States contracted during recreation costs $2.9B a year — 3 observations
Ohio health system acquiring Southwest Ohio Gastroenterology, Clinton County Outpatient Surgery — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.